IL151201A0 - Alkylated imidazopyridine derivatives and pharmaceutical compositions containing the same - Google Patents

Alkylated imidazopyridine derivatives and pharmaceutical compositions containing the same

Info

Publication number
IL151201A0
IL151201A0 IL15120101A IL15120101A IL151201A0 IL 151201 A0 IL151201 A0 IL 151201A0 IL 15120101 A IL15120101 A IL 15120101A IL 15120101 A IL15120101 A IL 15120101A IL 151201 A0 IL151201 A0 IL 151201A0
Authority
IL
Israel
Prior art keywords
same
pharmaceutical compositions
compositions containing
imidazopyridine derivatives
alkylated
Prior art date
Application number
IL15120101A
Other languages
English (en)
Original Assignee
Altana Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Altana Pharma Ag filed Critical Altana Pharma Ag
Publication of IL151201A0 publication Critical patent/IL151201A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/14—Ortho-condensed systems
    • C07D491/147—Ortho-condensed systems the condensed system containing one ring with oxygen as ring hetero atom and two rings with nitrogen as ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/14—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IL15120101A 2000-03-29 2001-03-28 Alkylated imidazopyridine derivatives and pharmaceutical compositions containing the same IL151201A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00106696 2000-03-29
PCT/EP2001/003507 WO2001072754A1 (en) 2000-03-29 2001-03-28 Alkylated imidazopyridine derivatives

Publications (1)

Publication Number Publication Date
IL151201A0 true IL151201A0 (en) 2003-04-10

Family

ID=8168272

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15120101A IL151201A0 (en) 2000-03-29 2001-03-28 Alkylated imidazopyridine derivatives and pharmaceutical compositions containing the same

Country Status (24)

Country Link
US (1) US6916825B2 (cs)
EP (1) EP1313739B1 (cs)
JP (1) JP2003528876A (cs)
KR (1) KR100823762B1 (cs)
CN (1) CN1213049C (cs)
AT (1) ATE332302T1 (cs)
AU (1) AU783764B2 (cs)
BR (1) BR0109542A (cs)
CA (1) CA2404460A1 (cs)
CZ (1) CZ20023116A3 (cs)
DE (1) DE60121345T2 (cs)
EA (1) EA005215B1 (cs)
ES (1) ES2267737T3 (cs)
HK (1) HK1056173A1 (cs)
HR (1) HRP20020853A2 (cs)
HU (1) HUP0300578A3 (cs)
IL (1) IL151201A0 (cs)
MX (1) MXPA02009552A (cs)
NO (1) NO20024597D0 (cs)
NZ (1) NZ520835A (cs)
PL (1) PL357811A1 (cs)
SK (1) SK13872002A3 (cs)
WO (1) WO2001072754A1 (cs)
ZA (1) ZA200207636B (cs)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA02009550A (es) * 2000-03-29 2004-05-14 Altana Pharma Ag Derivados de pirano (2,3,c)imidazo(1,2-a]piridina para el tratamiento de trastornos gastrointestinales.
BR0109483A (pt) 2000-03-29 2003-06-10 Altana Pharma Ag Pró-drogas de derivados de imidazopiridina
CA2426616A1 (en) * 2000-10-25 2002-05-02 Altana Pharma Ag Polysubstituted imidazopyridines as gastric secretion inhibitors
KR20040023697A (ko) * 2001-08-03 2004-03-18 알타나 파마 아게 위장관계 장애의 치료를 위한 알킬 치환 이미다조피리딘
DE10145457A1 (de) * 2001-09-14 2003-04-03 Basf Ag Substituierte Imidazo[1,2-a]-5,6,7,8-tetrahydropyridin-8-one, Verfahren zu ihrer Herstellung, sowie deren Verwendung zur Herstellung von Imidazo[1,2,-a]pyridinen
JP2005519933A (ja) 2002-02-15 2005-07-07 アルタナ　ファルマ　アクチエンゲゼルシャフト 三環式ｎ−アシル化合物
CN100384842C (zh) 2002-11-19 2008-04-30 奥坦纳医药公司 8-取代的咪唑并吡啶类化合物
PL375933A1 (en) * 2002-12-20 2005-12-12 Altana Pharma Ag 8-trialkylsiloxy-2-methyl-9-phenyl-7-oxo-7,8,9,10-tetrahydroimidazo[1,2-h][1,7]naphthyridines
WO2004071391A2 (en) * 2003-02-17 2004-08-26 Altana Pharma Ag Imidazopyridines containing combinations and their use in treating gastrointestinal inflammatory disorders
AR044129A1 (es) 2003-05-06 2005-08-24 Altana Pharma Ag Compuestos intermedios de imidazopiridina. proceso de preparacion.
CN1874772A (zh) 2003-11-03 2006-12-06 阿斯利康(瑞典)有限公司 治疗隐匿性胃食管反流的咪唑并[1,2－a]吡啶衍生物
WO2005058894A1 (en) 2003-12-19 2005-06-30 Altana Pharma Ag Intermediates for the preparation of tricyclic dihydropyrano -imidazo -pyridines derivatives
US7215655B2 (en) * 2004-01-09 2007-05-08 Interdigital Technology Corporation Transport format combination selection in a wireless transmit/receive unit
AR047605A1 (es) * 2004-02-17 2006-01-25 Altana Pharma Ag Imidazopiridinas triciclicas e intermediarios en la sintesis de las mismas,sus procesos de preparacion,composiciones farmaceuticas que los contienen y usos.
CA2582256A1 (en) * 2004-10-01 2006-04-13 Altana Pharma Ag Substituted tricyclic benzimidazoles
EP1934215A1 (en) * 2005-09-22 2008-06-25 Nycomed GmbH Isotopically substituted imidazopyridine derivatives for the treatment of gastrointestinal disorders
WO2008058990A1 (en) * 2006-11-16 2008-05-22 Nycomed Gmbh 7,7-disubstituted pyrano-[2,3-c]-imidazo-[1,2-a]-pyridine derivatives and their use as gastric acid secretion inhibitors
EP2291348A4 (en) 2008-05-20 2013-05-15 Neurogesx Inc WATER-SOLUBLE ACETAMINOPHENANALOGA
AU2009249069A1 (en) 2008-05-20 2009-11-26 Neurogesx, Inc. Carbonate prodrugs and methods of using the same
MX2017007377A (es) * 2014-12-06 2017-11-06 Intra-Cellular Therapies Inc Compuestos organicos.

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4468400A (en) 1982-12-20 1984-08-28 Schering Corporation Antiulcer tricyclic imidazo [1,2-a]pyridines
SE9401197D0 (sv) * 1994-04-11 1994-04-11 Astra Ab Active compounds
EA002402B1 (ru) * 1997-03-24 2002-04-25 Бык Гульден Ломберг Хемише Фабрик Гмбх Тетрагидропиридо-соединения
CA2289542A1 (en) * 1997-05-28 1998-12-03 Byk Gulden Lomberg Chemische Fabrik Gmbh Fused dihydropyrans
HUP0001555A3 (en) 1997-10-30 2001-01-29 Altana Pharma Ag Tetrahydro-imidazo-naphthyridine derivatives, pharmaceutical compositions thereof and process for their preparation
MXPA02009550A (es) * 2000-03-29 2004-05-14 Altana Pharma Ag Derivados de pirano (2,3,c)imidazo(1,2-a]piridina para el tratamiento de trastornos gastrointestinales.
BR0109483A (pt) * 2000-03-29 2003-06-10 Altana Pharma Ag Pró-drogas de derivados de imidazopiridina
ATE356131T1 (de) * 2000-03-29 2007-03-15 Altana Pharma Ag Tricyclische imidazopyridine

Also Published As

Publication number Publication date
MXPA02009552A (es) 2004-05-14
WO2001072754A9 (en) 2004-05-06
US6916825B2 (en) 2005-07-12
NO20024597L (no) 2002-09-25
EA200200876A1 (ru) 2003-04-24
CZ20023116A3 (cs) 2003-01-15
NZ520835A (en) 2004-05-28
US20030158193A1 (en) 2003-08-21
HUP0300578A3 (en) 2009-01-28
JP2003528876A (ja) 2003-09-30
CN1422274A (zh) 2003-06-04
KR20030015221A (ko) 2003-02-20
NO20024597D0 (no) 2002-09-25
HUP0300578A2 (hu) 2003-07-28
ES2267737T3 (es) 2007-03-16
EP1313739A1 (en) 2003-05-28
AU4422501A (en) 2001-10-08
AU783764B2 (en) 2005-12-01
KR100823762B1 (ko) 2008-04-21
WO2001072754A8 (en) 2003-02-13
CA2404460A1 (en) 2001-10-04
SK13872002A3 (sk) 2003-02-04
PL357811A1 (en) 2004-07-26
ZA200207636B (en) 2003-04-04
WO2001072754A1 (en) 2001-10-04
ATE332302T1 (de) 2006-07-15
EP1313739B1 (en) 2006-07-05
DE60121345D1 (de) 2006-08-17
DE60121345T2 (de) 2007-07-19
EA005215B1 (ru) 2004-12-30
HK1056173A1 (en) 2004-02-06
CN1213049C (zh) 2005-08-03
BR0109542A (pt) 2003-06-10
HRP20020853A2 (en) 2005-02-28

Similar Documents

Publication Publication Date Title
IL151201A0 (en) Alkylated imidazopyridine derivatives and pharmaceutical compositions containing the same
BG105270A (en) Tetrahydropyridoethers
PL358281A1 (en) Novel compounds
IL151200A0 (en) Tricyclic imidazopyridine prodrug derivatives and pharmaceutical compositions containing the same
CA2461622A1 (en) Substituted benzimidazole compounds and their use for the treatment of cancer
DE69938192D1 (en) Imidazonaphthyridine
IL131407A0 (en) Tetrahydropyrido compounds medicaments containing the same and the use thereof
IL151198A0 (en) Tricyclic imidazopyridine derivatives and pharmaceutical compositions containing the same
BG105731A (en) 3,3-biarylpiperidine and 2,2-biarylmorpholine derivatives
IL173629A0 (en) Imidazo(4,5-b) pyridine derivatives and pharmaceutical compositions containing the same
MY133140A (en) N-substituted azabicycloheptane derivatives, their preparation and use
MY116727A (en) Tetrahydropyrido compounds
MY133139A (en) N-substituted azabicycloheptane derivatives, their preparation and use